Improvement of Metabolic Syndrome in High-Fat Diet-Induced Mice by Yeast β-Glucan Is Linked to Inhibited Proliferation of Lactobacillus and Lactococcus in Gut Microbiota
Improvement of Metabolic Syndrome in High-Fat Diet-Induced Mice by Yeast β-Glucan Is Linked to Inhibited Proliferation of Lactobacillus and Lactococcus in Gut Microbiota
复制标题
酵母β-葡聚糖改善高脂饮食诱导的小鼠代谢综合征与抑制肠道菌群中乳杆菌和乳球菌的增殖有关
DOI：
10.1021/acs.jafc.1c00866
复制
发表时间：
2021-07-01
影响因子：
6.1
通讯作者：
Yuan, Qingxia
中科院分区：
文献类型：
--
作者：
Chen, Guijie;Chen, Dan;Yuan, Qingxia
There is growing evidence that prevention of metabolic syndrome (MS) by dietary fibers is intricately linked to gut microbiota. In the present work, the mice were fed a high-fat diet (HFD) and orally treated with yeast beta-glucan to further examine the effects of beta-glucan on MS and gut microbiota and the potential relationship between gut microbiota and its activity. After intervention for 10 weeks, it was found that the treatment of yeast beta-glucan could significantly improve the HFD-induced MS. Furthermore, pro-inflammatory cytokines in plasma including IL-6 and IL-1 beta were decreased. Yeast beta-glucan could regulate the diversity and composition of HFD-induced gut microbiota. Moreover, the relative abundances of Lactobacillus and Lactococcus, having significant positive correlation with metabolic changes, were decreased by beta-glucan, which might play a critical role in attenuation of MS. Our findings suggest that yeast beta-glucan shows promising application as a prebiotic for preventing MS and regulating gut microbiota.
